DRREDDY Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > drreddy

Technical Analysis

Technical Strength: 3.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 37.5. According to RSI analysis, drreddy is technically weak. 1.0 DRREDDY RSI Chart
MACD (?) MACD: -39.6 and Signal Line: -43.0. According to MACD analysis, drreddy is marginally strong. 7.0 DRREDDY MACD Chart
Simple Moving Average (?) According to simple moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 2646.218, 2762.31, 3053.802. 0.0 DRREDDY Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, drreddy is in a strong downtrend. Major resistance levels are 2655.647, 2750.566, 2985.785. 0.0 DRREDDY Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.268. 5.0 DRREDDY Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is below all levels. Resistance levels are 2802.9843 and 2879.525. Support level is 2555.2. 2.5 DRREDDY Fibonacci Retracement Chart
Average True Range (?) ATR: 46.7 NA DRREDDY Average True Range Chart
Average Directional Index (?) ADX is 29.9 which means DRREDDY is in a trend. NA DRREDDY Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 24, 2017
Open Price 2619.65
High Price 2626.75
Low Price 2590.05
Close Price 2612.8
Absolute Change 3.15
Percentage Change 0.121%
Weekly Change -1.82%
Monthly Change -0.699%
Yearly Change -15.5%
52-week high 3689.85
52-week low 2555.2
Corporate Actions
ExDate Purpose
July 18, 2016 AGM/DIV-RS 20 PER SHARE
July 10, 2015 AGM/DIV RS 20/- PER SHARE
July 11, 2014 AGM/DIV-RS 18 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.489
Confidence in Beta1.16%
Market Capital Rs. 44569.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 79.15
TTM Price-to-Earnings (P/E) Ratio 33
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 24 April 2017: Deliverable Quantity:4.27e+04 NA DRREDDY Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 24 April 2017: Daily Volatility:0.2407 NA DRREDDY Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 24 April 2017: PCR_OI:0.296 PCR:0.4 NA DRREDDY PCR Chart
Premium (?) 24 April 2017 Premium: 9.2 Futures OI:3121600.0 NA DRREDDY Premium Chart
Option_MAX_OI (?) 24 April 2017: Price:2612.8 Put with maximum OI:2600.0 Call with maximum OI:2700.0 NA DRREDDY Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
April 27, 2017 2622.0 3121600.0 3679.0 5141.0 2612.8
May 25, 2017 2631.1 716800.0 2279.0 3593.0 2612.8
June 29, 2017 2644.05 5400.0 19.0 20.0 2612.8

Announcements

April 24, 2017 Dr.Press Release. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 21, 2017, titled "Dr. Reddy's Laboratories announces the launch of
April 17, 2017 Dr.Press Release. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 14, 2017, titled "Intimation". Audit of our API Srikakulam Plant (SEZ) Andhra Pradesh by USFDA has been completed today with no observations
See all Announcements

Board Meetings

Date Meeting Date Purpose
April 18, 2017 May 12, 2017 intResults/Dividendter alia, to consider and approve the Audited Financial Results of the Company for the financial year ended March 31, 2017 and recommend dividend, if any, for the financial year 2016-17. Further, that the Company s trading window for dealing in securities by the Insiders is closed from April 26, 2017 and ending on May 14, 2017 (both days inclusive).
January 10, 2017 February 04, 2017 intResultster alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.
See all Board Meetings

DRREDDY is part of...

Index Weightage
NIFTY NA
CNXPHARMA NA

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 2556 Rs. 2573 Rs. 2593 Rs. 2610 Rs. 2630 Rs. 2647 Rs. 2666